MFWM
NVO

Motley Fool Wealth Management’s Novo Nordisk NVO Stock Holding History

Motley Fool Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
40,353
-15,009
-27% -$711K 0.17% 107
2025
Q4 		$2.82M Sell
55,362
-11,785
-18% -$603K 0.22% 101
2025
Q3 		$3.73M Sell
67,147
-9,471
-12% -$554K 0.25% 104
2025
Q2 		$5.29M Sell
76,618
-13,220
-15% -$899K 0.32% 94
2025
Q1 		$6.24M Sell
89,838
-12,297
-12% -$1.02M 0.37% 90
2024
Q4 		$8.69M Sell
102,135
-10,299
-9% -$1.11M 0.45% 75
2024
Q3 		$13.4M Sell
112,434
-11,430
-9% -$1.52M 0.67% 55
2024
Q2 		$17.6M Sell
123,864
-5,140
-4% -$681K 0.9% 35
2024
Q1 		$16.6M Sell
129,004
-63,464
-33% -$7.55M 0.86% 36
2023
Q4 		$19.9M Sell
192,468
-2,372
-1% -$235K 1.04% 26
2023
Q3 		$17.7M Buy
194,840
+464
+0.2% +$40.9K 1.03% 29
2023
Q2 		$15.7M Sell
194,376
-1,838
-0.9% -$150K 0.93% 37
2023
Q1 		$15.6M Sell
196,214
-3,362
-2% -$238K 0.98% 35
2022
Q4 		$13.5M Sell
199,576
-6,240
-3% -$366K 0.94% 39
2022
Q3 		$10.3M Sell
205,816
-2,862
-1% -$153K 0.67% 50
2022
Q2 		$11.6M Sell
208,678
-7,032
-3% -$390K 0.73% 44
2022
Q1 		$12M Sell
215,710
-127,070
-37% -$6.52M 0.57% 58
2021
Q4 		$19.2M Sell
342,780
-2,846
-0.8% -$154K 0.84% 40
2021
Q3 		$16.6M Sell
345,626
-2,444
-0.7% -$118K 0.72% 45
2021
Q2 		$14.6M Buy
348,070
+1,656
+0.5% +$64.2K 0.61% 53
2021
Q1 		$11.7M Buy
346,414
+144
+0% +$5.13K 0.52% 61
2020
Q4 		$12.1M Buy
346,270
+9,798
+3% +$339K 0.54% 58
2020
Q3 		$11.7M Buy
336,472
+13,638
+4% +$455K 0.61% 53
2020
Q2 		$10.6M Sell
322,834
-1,158
-0.4% -$37K 0.6% 53
2020
Q1 		$9.75M Sell
323,992
-11,950
-4% -$356K 0.7% 45
2019
Q4 		$9.72M Sell
335,942
-54
-0% -$1.5K 0.58% 56
2019
Q3 		$8.69M Sell
335,996
-118
-0% -$2.98K 0.57% 53
2019
Q2 		$8.58M Buy
336,114
+1,538
+0.5% +$38K 0.54% 58
2019
Q1 		$8.75M Buy
334,576
+6,946
+2% +$171K 0.56% 55
2018
Q4 		$7.55M Buy
327,630
+10,032
+3% +$223K 0.57% 56
2018
Q3 		$7.49M Buy
317,598
+10,726
+3% +$262K 0.48% 67
2018
Q2 		$7.08M Buy
306,872
+13,866
+5% +$330K 0.5% 58
2018
Q1 		$7.21M Buy
293,006
+19,600
+7% +$515K 0.53% 60
2017
Q4 		$7.34M Buy
273,406
+14,226
+5% +$362K 0.56% 54
2017
Q3 		$6.24M Buy
259,180
+31,664
+14% +$716K 0.53% 56
2017
Q2 		$4.88M Buy
+227,516
New +$4.59M 0.44% 67

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Motley Fool Wealth Management's NVO Position: Q1 2026 in Review

Motley Fool Wealth Management reduced its Novo Nordisk (NVO) stake by 27% in Q1 2026, selling an estimated $711K and leaving 40,353 shares worth $1.48M. The position accounts for 0.17% of the portfolio, ranked #107.

Motley Fool Wealth Management first reported a position in NVO in Q2 2017 and has held it in 36 quarters since. The position peaked at $19.9M in Q4 2023. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Motley Fool Wealth Management held 40,353 shares of Novo Nordisk worth $1.48M as of Q1 2026.
  • Motley Fool Wealth Management sold 15,009 Novo Nordisk shares in Q1 2026, an estimated $711K.
  • Novo Nordisk made up 0.17% of Motley Fool Wealth Management's portfolio in Q1 2026, its #107 holding.
  • Motley Fool Wealth Management first reported a position in Novo Nordisk in Q2 2017 and has held it in 36 quarters since.
  • Motley Fool Wealth Management's Novo Nordisk position peaked at $19.9M in Q4 2023.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Motley Fool Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.